Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001718813 | SCV000512444 | likely benign | not provided | 2019-12-10 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000631752 | SCV000752842 | likely benign | Long QT syndrome | 2023-12-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002379293 | SCV002699600 | likely benign | Cardiovascular phenotype | 2020-06-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001718813 | SCV003916802 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | CACNA1C: BP4, BP7 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003235206 | SCV003934656 | likely benign | not specified | 2023-05-06 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003897842 | SCV004713848 | likely benign | CACNA1C-related disorder | 2021-02-08 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |